RecruitingNCT03193541
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Sponsor
Cedars-Sinai Medical Center
Enrollment
900 participants
Start Date
Dec 30, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This study is evaluating a new urine-based blood marker test to determine whether it can accurately identify bladder cancer in people who have blood in their urine (a condition called microscopic haematuria — blood not visible to the eye, only detectable under a microscope or by lab test).
**You may be eligible if...**
- You are 18 years or older
- You have had blood detected in your urine within the past 3 months (confirmed by lab test)
- You are willing to give informed consent
**You may NOT be eligible if...**
- You have a prior history of bladder cancer
- You have had any other cancer (except non-melanoma skin cancer)
- You have an active urinary tract infection or urinary obstruction
- You have active kidney stones
- You have kidney insufficiency (poor kidney function)
- You have had recent urological procedures
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03193541
Related Trials
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT0741929527 locations
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT065031461 location
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
NCT069043651 location
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT000018231 location
DESTINY-PANTUMOUR04
NCT0712400017 locations